Tag: automated calprotectin test

BUHLMANN Debriefing- EuroMedLab 2019

BÜHLMANN Educational Workshop at EuroMedLab 2019 The BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin testing was a great success.  This workshop offered insightful presentations from three laboratories discussing the process of stool sample pre-analytics and how they worked to find a solution to cope with continuously increasing test numbers.
Continue Reading

BÜHLMANN fCAL® turbo Success Story- Freeman Hospital, Newcastle

The Benefits of Switching to BÜHLMANN Assay for Calprotectin Testing Dr. Elodie Hanon, Prinicpal Clinial Scientist at the Freeman Hospital, Newcastle, UK (Article courtesy of BÜHLMANN’s UK distributor, Alpha Laboratories.) Highlight from this Perspective Article "We went live with the fCAL turbo in March 2018, and there really have been no issues. The turn-around time
Continue Reading

The Way to Total Automation of Calprotectin Measurement in Faeces with BUHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo: Schallberger, Y. et al. The Way to Total Automation of Calprotectin Measurement in Faeces with BUHLMANN fCAL® turbo. Swiss MedLab 2016, 13. – 16. June 2016. Berne, Switzerland. Poster Highlights from this Publication “ ...Combined with the CALEX® Cap extraction device the fecal calprotectin testing workflow is further simplified thus reducing hands-on-time by 70%. " Read Citation
Continue Reading

BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® turbo Automated Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, June 26, 2019: BÜHLMANN Laboratories AG, is proud to announce it received United States Food and Drug
Continue Reading

Evaluation BÜHLMANN fCAL® Turbo Test – Kantonsspital St.Gallen

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin, KS St. Gallen, Switzerland *Senior Laboratory Technician Core Lab, **Deputy Head of Department Core Lab/FAMH Candidate Clinical Chemistry, Centre for Laboratory Medicine, Frohbergstrasse
Continue Reading

Experience with BUHLMANN fCAL turbo- SYNLAB

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 A Report of A. Suter* and Dr. C. Fuhrer** from SYNLAB *BMA HF/ Fachleiterin, **Head of Core Lab, FAMH Clinical Chemistry, NF hematology, microbiology and immunology; SYNLAB Suisse SA, Alpenquai 14, 6002 Lucerne, Switzerland
Continue Reading

BÜHLMANN fCAL® turbo Customer Testimonials

  View a compilation of twelve user testimonials from UK, Ireland, Switzerland and France that have been published so far for the BÜHLMANN fCAL® turbo. Find valuable highlights, perspectives, advice and details about the successful applications of this automated calprotectin assay from each laboratory.   Read Testimonials
Continue Reading

Join Us at CSCC 2018 in Ottowa!

Canadian Society for Clinical Chemists (CSCC) 2018 BUHLMANN Diagnostics Corp  Booth: #410 June 03 - 06, 2018 | Fairmont Château Laurier Hotel. | Ottawa, ON Learn More Come by our booth to get an update on our Calprotectin,Therapeutic Drug Monitoring, Chemistry, Neuroimmunology, and Cellular Allergy portfolios Calprotectin and TDM: IBDoc®, the ONLY in-vitro diagnostic POC and home testing
Continue Reading

Connect with BUHLMANN at DDW 2018

Digestive Diseases Week (DDW) 2018 BUHLMANN Diagnostics Corp  Booth: #2347 June 02-05, 2018 | Walter E. Washington Convention Center | Washington, DC Learn More Come by our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio: Quantum Blue® platform offering rapid and quantitative results for fecal calprotectin, serum calprotectin, CRP and serum infliximab trough levels  (Additional trough level
Continue Reading

Évaluation du test BÜHLMANN fCAL® turbo au City Hospital Triemli de Zurich

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 English Version ENTRETIEN AVEC ANITA GRÜNAUER ET PREDRAG NESIC, Hôpital municipal de Zurich, Triemli Madame Grünauer, Monsieur Nesic, votre équipe du laboratoire de chimie clinique de l’hôpital de Triemli a décidé d’utiliser le test
Continue Reading